Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2019-10-02
2021-04-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Histamine in Muscle Protein Synthesis Following Resistance Training
NCT06152497
Influence of Endurance Exercise and Histamine Receptors on the Gene Expression in Skeletal Muscle
NCT05131555
Histamine as a Molecular Transducer of Adaptation to Exercise
NCT05206227
Histamines and Central Hemodynamics
NCT07285031
Effect of an H1 Receptor Antagonist on Exercise Performance in Hypoxia
NCT03192488
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
6 weeks high-intensity interval training + placebo intake
Lactose
Placebo: Lactose capsules
High-intensity interval training (HIIT)
6 weeks HIIT
Blockade
6 weeks high-intensity interval training + histamine H1/H2 receptor blockade
Fexofenadine Hydrochloride
H1 receptor antagonist: 540 mg Fexofenadine Hydrochloride
Famotidine
H2 receptor antagonist: 40 mg Famotidine
High-intensity interval training (HIIT)
6 weeks HIIT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactose
Placebo: Lactose capsules
Fexofenadine Hydrochloride
H1 receptor antagonist: 540 mg Fexofenadine Hydrochloride
Famotidine
H2 receptor antagonist: 40 mg Famotidine
High-intensity interval training (HIIT)
6 weeks HIIT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Caucasian
Exclusion Criteria
* Medication use
* Smoking
* Excessive alcohol consumption
* Seasonal allergies
18 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Research Foundation Flanders
OTHER
University of Copenhagen
OTHER
University Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Movement and Sports Sciences, Ghent University
Ghent, Oost-Vlaanderen, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HIST-TRAINING (BC-06009)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.